The Efficacy of Convalescent Plasma Use in Critically Ill COVID-19 Patients

The Efficacy of Convalescent Plasma Use in Critically Ill COVID-19 Patients

<i>Background and Objectives:</i> On 24 March 2020, the United States Food and Drug Administration (FDA) announced the approval of convalescent plasma therapy for critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an emergency investigational new...

Full description

Bibliographic Details
Main Authors: Livius Tirnea, Felix Bratosin, Iulia Vidican, Bianca Cerbu, Mirela Turaiche, Madalina Timircan, Madalin-Marius Margan, Iosif Marincu
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Medicina
Subjects:
convalescent plasma
COVID-19
critically ill
transfusion
SARS CoV-2
Online Access:https://www.mdpi.com/1648-9144/57/3/257

Internet

https://www.mdpi.com/1648-9144/57/3/257

Similar Items